CAPLACIZUMAB

1784 reported adverse events

These side effects are most commonly reported by patients taking CAPLACIZUMAB:

# Side effect Count
0 PRODUCT USE IN UNAPPROVED INDICATION 619
1 OFF LABEL USE 208
2 ADAMTS13 ACTIVITY DECREASED 161
3 EPISTAXIS 133
4 PLATELET COUNT DECREASED 133
5 FATIGUE 111
6 CONTUSION 89
7 THROMBOTIC THROMBOCYTOPENIC PURPURA 84
8 HEADACHE 83
9 INJECTION SITE PAIN 82
See all common reactions for CAPLACIZUMAB

CAPLACIZUMAB is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 ADAMTS13 INHIBITOR SCREEN ASSAY 3 1.0000
1 ADAMTS13 ACTIVITY ASSAY 1 1.0000
2 ADAMTS13 ACTIVITY ABNORMAL 73 0.8022
3 PLACENTAL OEDEMA 8 0.7273
4 ADAMTS13 ACTIVITY DECREASED 161 0.6216
5 ADAMTS13 ACTIVITY INCREASED 4 0.5000
6 HAEMORRHAGIC PANCREATIC CYST 1 0.5000
7 POST TRANSFUSION PURPURA 2 0.2500
8 SPLENIC ARTERY EMBOLISATION 1 0.1429
9 STRESS ULCER HAEMORRHAGE 1 0.1250
See all enriched reactions for CAPLACIZUMAB